SEC Form 4
Humacyte, Inc. (HUMA) insider trading
In the 12 months to Oct 26, 2026, 3 HUMA insiders reported open-market purchases of $90.2K across 5 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $90.2K
- 5 filings
Who traded HUMA, and when
- Purchase
HUMA daily close from Oct 27, 2025 to Oct 26, 2026, between $0.35 and $1.70, last $0.40. 0 sale and 5 purchase filings by 3 insiders, marked at their filing dates. Kathleen Sebelius, Director: bought $50.0K across 1 filing, first filed May 20, 2026, last May 20, 2026. Keith Anthony Jones, Director: bought $30.4K across 3 filings, first filed Aug 19, 2026, last Sep 15, 2026. Michael T. Constantino, Director: bought $9.8K across 1 filing, first filed May 20, 2026, last May 20, 2026.
Largest mark · tap a row for others
Kathleen Sebelius · Director
Purchase $50,000
56,818 shares at $0.88 avg
Filed May 20, 2026 · traded May 19
Close on filing date $0.92
Kathleen Sebelius · Director
Director
$50.0K boughtKeith Anthony Jones · Director
Director
$30.4K boughtMichael T. Constantino · Director
Director
$9.8K boughtOpen-market trades
5 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Kathleen Sebelius | Director | — | $50.0K | 1 | — | |
| Keith Anthony Jones | Director | — | $30.4K | 3 | — | |
| Michael T. Constantino | Director | — | $9.8K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Keith Anthony Jones Director | Purchase | 10,000 | $0.56 | $5.6K | 50,000 | |
traded | Keith Anthony Jones Director | Purchase | 10,000 | $0.69 | $6.9K | 40,000 | |
traded | Keith Anthony Jones Director | Purchase | 30,000 | $0.59 | $17.8K | 30,000 | |
traded | Kathleen Sebelius Director | Purchase | 56,818 | $0.88 | $50.0K | 148,025 | |
traded | Michael T. Constantino Director | Purchase | 11,000 | $0.89 | $9.8K | 43,950 |
GET /stocks/filings/vX/form-4?tickers=HUMA&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"HUMA"
],
"issuer_cik": "0001818382",
"owner_cik": "0002026411",
"accession_number": "0001193125-26-391889",
"form_type": "4",
"filing_date": "2026-09-15",
"period_of_report": "2026-09-14",
"issuer_name": "Humacyte, Inc.",
"issuer_trading_symbol": "HUMA",
"owner_name": "Jones Keith Anthony",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-14",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 0.562,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 50000,
"transaction_value": 5620.000000000001,
"direct_or_indirect": "D"
},
{
"tickers": [
"HUMA",
"HUMAW"
],
"issuer_cik": "0001818382",
"owner_cik": "0002026411",
"accession_number": "0001193125-26-361081",
"form_type": "4",
"filing_date": "2026-08-21",
"period_of_report": "2026-08-20",
"issuer_name": "Humacyte, Inc.",
"issuer_trading_symbol": "HUMA",
"owner_name": "Jones Keith Anthony",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-20",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 0.693,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 40000,
"transaction_value": 6929.999999999999,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 4 records
- Tax withholding (sold to cover)2 records
- Grants and awards2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Humacyte, Inc.'s CEO sold stock?
No. Laura E. Niklason (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is HUMA’s insider data?
These are HUMA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track HUMA insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for HUMA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.